본문 바로가기
KERD
논문KCI 등재

The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis

2

조회

0

다운로드

6

인용

0

참고문헌

주제분류의학일반

초록

Abstract

Cervical cancer is one of the leading world causes of cancer morbidity and mortality in woman, with more than 98% related to a human papillomavirus (HPV) infection origin. Infection with specific subtypes of HPV has been strongly implicated in cervical carcinogenesis. The identification and functional verification of host proteins associated with HPV E6 and E7 oncoproteins may provide useful information in understanding cervical carcinogenesis and the development of cervical cancerspecific markers. The advent of functional genomics and proteomics has provided hope of discovering novel biological markers for use in the screening, early diagnosis, prognostication and prediction of response to therapy. Herein, we review the studies where the profiles of host proteins associated with HPV E6 and E7 oncoproteins in cervical cancer were generated.

참고문헌 (28)

  1. "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide", 189, pp.12~9 (1999)
  2. "Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein", 40, pp.1196~204 (2001)
  3. "Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation", 67, pp.547~56 (1991)
  4. "Interactions of the human papillomavirus E7 protein with cell cycle regulators", 7, pp.327~37 (1996)
  5. "The retinoblastoma gene family in differentiation and development", 18, pp.7873~82 (1999)
  6. "Adenovirus E1A,simian virus 40 tumor antigen,and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product", 89, pp.4549~53 (1992)
  7. "Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes", 9, pp.2335~49 (1995)
  8. "The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis", 279, pp.25729~44 (2004)
  9. "Genomic and proteomic expression patterns in HPV-16 E6 gene transfected stable human carcinoma cell lines", 23, pp.826~35 (2004)
  10. "The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53", 63, pp.1129~36 (1990)
  11. "Bax and Bak independently promote cytochrome C release from mitochondria", 277, pp.14127~34 (2002)
  12. "sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis", 8, pp.705~11 (2001)
  13. "TRAF6 is a signal transducer for interleukin-1", 383, pp.443~6 (1996)
  14. "Inactivation of G2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6", 8, pp.1105~14 (1997)
  15. "Functional inactivation of p73 a homolog of p53 tumor suppressor protein, by the human papillomavirus E6 proteins.", 91, pp.822~7 (2001)
  16. "Interaction of HPV E6 oncoprotein with the novel protein, BARD1 (BRCA1-associated ring domain 1) and its biological role. 22nd Intl." (2005), Papillomavirus Conference
  17. "Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis", 275, pp.6764~9 (2000)
  18. "The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha", 259, pp.305~13 (1999)
  19. "Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics", 4, pp.839~48 (2004)
  20. "A key role of the hSNF5", INI1 tumour suppressor in the control of the G1-S transition of the cell cycle, 2002, pp.21, 403~12
  21. "SWI", SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription, 2002, pp.277, 22330~7
  22. "Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers", 152, pp.15~22 (2000)
  23. "Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCaT keratinocytes by proteomics", 99, pp.142~52 (2005)
  24. "Anti-inflammatory activity of neutrophil elastase inhibitors", 4, pp.556~65 (2003)
  25. "Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line", 32, pp.279~85 (1993)
  26. "Cytosolic chaperonin is up-regulated during cell growth Preferential expression and binding to tubulin at G", S transition through early S phase, 1999, pp.274, 37070~8
  27. "Interaction of human Ku70 with TRF2", 481, pp.81~5 (2000)
  28. "a novel inhibitor of apoptosis protein family member", 276, pp.3238~46 (2001)

관련 논문AI추천

이 간행물의 다른 논문 (9건)

Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence DatabaseKyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Hai-Rim Shin, Seon-Hee Yim, Choong Won Lee, Ze-Hong Woo, Tae-Yong Lee, 최진수, Yoon-Ok Ahn, Jong-Myon Bae, Jung-Kyu Lee, Hong-In Noh, Jong-Koo Lee, Paola Pisani, Soon Yong Lee, Jae-Gahb Park, Cheol-In Yoopp. 325-331Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-small Cell Lung CancerHanlim Moon, Joo-Hang Kim, Myung-Ju Ahn, Jung-Ae Lee, Dae-Sik Hong, Hee-Sook Park, Nam-Su Lee, Su-Taek Uh, Se-Kyu Kim, Suk-Chul Yang, Keun-Seok Lee, Chang-Yeol Yim, Yong-Chul Lee, Chul-Soo Kim, Kab-Do Jung, Yl-Sub Lee, 이상재, Moon-Hee Lee, Jong-Ho Won, 최정혜pp. 332-338The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m2) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated With Platinum-based ChemotherapyByoung Yong Shim, So Hyang Song, Meyung Im Ahn, Eun Jung Hong, Sung Whan Kim, Min Seop Jo, Deog Gon Cho, Kyu Do Cho, Jinyoung Yoo, Chi Hong Kim, Suzy Kim, Hoon-Kyo Kimpp. 339-343Clinical Experience of Patients with Ductal Carcinoma In Situ of the Breast Treated with Breast-Conserving Surgery plus Radiotherapy: A Preliminary ReportWoo-Chan Park, Byung-Joo Song, Se-Jeong Oh, Jong-Man Won, Seung-Nam Kim, Su-Mi Chung, Yoon-Kyeong Oh, Mi-Ryeong Ryu, Ji-Young Jang, Hyung-Chul Kwon, Yeon-Sil Kim, Sung-Whan Kim, Chul-Seung Kay, Sei-Chul Yoonpp. 344-348A Multi-Center, Phase II Clinical Trial of PadexolTM (Paclitaxel) and Cisplatin for Patients Suffering with Advanced Gastric CancerHong Suk Song, Young Rok Do, 김민경, Won Sik Lee, Jin Ho Baek, 김종광, 이경희, 현명수, Keon Uk Parkpp. 349-353